Search results
Found 1364 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Cochrane ENT awarded NIHR funding for COVID-19 project
Coronavirus COVID-19 General Research
11 December 2020
Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.
National COVID-19 Infections Survey reveals changes to pandemic over time
Coronavirus COVID-19 General Research
11 December 2020
Data from the National COVID-19 Infection Survey, done in partnership between the University of Oxford, the Office of National Statistics, Public Health England, University of Manchester and the Wellcome Trust, has revealed detailed characteristics of England’s coronavirus pandemic, including which factors have contributed most to case numbers over different phases and the prevalence of asymptomatic infections.
Key step for hepatitis research as patient database created
General Research
11 December 2020
For the first time, a comprehensive database comprising an initial cohort of more than 1,300 patients with chronic hepatitis B or hepatitis C infections has been developed for potential future research into the conditions.
University spinout PepGen awarded major financing to target Duchenne muscular dystrophy
Awards and Appointments General Innovation
9 December 2020
PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.
£3M invested to drive forward early translation through five new Oxford-Bristol Myers Squibb Fellowships
Awards and Appointments General Innovation
9 December 2020
Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced today*. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.
University of Oxford awarded major European Research Council funding
Awards and Appointments General Research
9 December 2020
European Research Council grants worth more than €16.3 million have today been awarded to eight University of Oxford researchers for a range of cutting-edge projects.
First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
Clinical Trials Coronavirus COVID-19 General Research
8 December 2020
Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.
Philharmonic Orchestra film special tribute concert for the Oxford vaccine team
Coronavirus COVID-19 General
7 December 2020
A special concert to say thank you and pay tribute to the achievements of the Oxford vaccine team has been recorded at the Sheldonian Theatre for a film screening in time for Christmas.
$10 million gift for new Nanoscience Institute in Oxford
General
3 December 2020
A new institute for nanoscience research is to open in Oxford thanks to a $10 million gift from The Kavli Foundation.
Hidden damage to lungs from COVID-19 revealed in new research study from University of Oxford & Sheffield
Coronavirus COVID-19 General Research
2 December 2020
Early findings from a study into longer-term damage amongst patients recovering from COVID-19 suggest that the use of cutting-edge scanning techniques may detect previously unseen lung damage.
SCALOP team discover new pancreatic cancer biomarker
General Research
30 November 2020
The discovery of pancreatic cancer biomarkers (naturally occurring molecules, genes or characteristics which can be used to confirm the presence or predict the outcome of a cancer) is vital in understanding patient outcomes and finding new therapeutic targets.
A clue to how a memory-enhancing pill might work
General Research
27 November 2020
Hundreds of dietary supplements have been reported to improve cognitive and emotional function in humans, but few have scientific foundation. A new study from the Department of Physiology, Anatomy & Genetics (DPAG) provides fresh insight into how dietary magnesium supplementation can influence memory performance.
Inhaled corticosteroids to be investigated as a possible treatment for Covid-19 in national PRINCIPLE Trial
Coronavirus COVID-19 General Research
27 November 2020
In Covid-19, inhaled budesonide may prevent damaging inflammation, stop the virus from getting into lung cells and inhibit viral replication.
New MRI technique could detect early signs of heart failure in cancer patients following chemotherapy
General Research
25 November 2020
New research led by Department of Physiology, Anatomy & Genetics researcher Dr Kerstin Timm shows that a recently developed imaging technique can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.
Oxford University breakthrough on global COVID-19 vaccine
Coronavirus COVID-19 General Research
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
People in prison should be prioritised for any COVID-19 vaccine
Coronavirus COVID-19 General Research
20 November 2020
Preventing serious complications from COVID-19 in potentially vulnerable populations in high risk environments, such as prisons, and preventing spread to surrounding communities needs a coordinated evidence-based approach to managing outbreaks of COVID-19 in prison settings.
Prior COVID-19 infection offers protection from re-infection for at least six months
Coronavirus COVID-19 General Research
20 November 2020
A new study suggests that individuals who have previously had COVID-19 are highly unlikely to contract the illness again, for at least six months following their first infection.
Transplant kidney survival rate improves with new method of transportation
General Research
20 November 2020
New research by the Consortium for Organ Preservation in Europe (COPE) has found that a new method to transport donor kidneys, which uses a combination of cold perfusion with oxygen, can significantly improve transplant results, with less graft failure, better function and lower rejection of the kidney when compared to cold perfusion alone. For patients who need a kidney transplant this is a big step forward. The study, carried out in Belgium, The Netherlands and the UK, was published today in The Lancet.
Viruses shown to evolve as a result of different immune responses in different ethnic populations
Coronavirus COVID-19 General Research
20 November 2020
New research into the HIV-1 virus has shed light on an important factor in the evolution of viruses, which is likely also to affect SARS-CoV-2 (the virus which causes COVID-19). This new insight could have important implications for vaccine development.
Oxford coronavirus vaccine produces strong immune response in older adults
Clinical Trials Coronavirus COVID-19 General Research
19 November 2020
The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.